Written questions by Spencer.

Innovation and Technology, how much Government funding into uveitis research there was in 2023-24; and which public bodies provided that funding.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was awarded £20 million funding for a five-year period starting from December 2022.UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally. UKRI delivers a substantial portfolio of researcher-led projects. This includes a wide variety of areas including physiological, biological, and mechanistic aspects that are applicable to many eye diseases and disorders of vision.Details of UKRI and NIHR funding on specific areas is provided in the table below: NIHR funding in FY 2023/24UKRI Funding in 2023/24UveitisNIHR did not commit any specific funding for uveitis research in financial year 2023-24.The total commitment across UKRI in 2023-24 for uveitis research was £248,809 for 1 award (1 award from MRC).CataractNIHR allocated £2,584,219 for research concerning cataracts research in financial year 2023-24.The total commitment across UKRI in 2023-24 for cataract research was £516,566 for 1 award (1 award from Innovate UK).KeratoconusNIHR allocated £49,458 for research concerning keratoconus research in financial year 2023-24.The total commitment across UKRI in 2023-24 for keratoconus research was £516,566 for 1 award (1 award from Innovate UK).BlepharitisNIHR did not commit any specific funding for blepharitis research in financial year 2023-24.UKRI did not commit any specific funding for blepharitis research in 2023-24.Central Retinal Vein OcclusionNIHR allocated £70,000 for research concerning central retinal vein occlusion in the financial year 2023-24.UKRI did not commit any specific funding for central retinal vein occlusion research in 2023-24.Retinal Detachment Occlusion ResearchNIHR did not commit any specific funding for retinal detachment occlusion research in financial year of 2023-24.The total commitment across UKRI in 2023-24 for retinal detachment occlusion research was £1,223,830 for 1 award (1 award from MRC).

Innovation and Technology, how much Government funding into central retinal vein occlusion research there was in 2023-24; and which public bodies provided that funding.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was awarded £20 million funding for a five-year period starting from December 2022.UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally. UKRI delivers a substantial portfolio of researcher-led projects. This includes a wide variety of areas including physiological, biological, and mechanistic aspects that are applicable to many eye diseases and disorders of vision.Details of UKRI and NIHR funding on specific areas is provided in the table below: NIHR funding in FY 2023/24UKRI Funding in 2023/24UveitisNIHR did not commit any specific funding for uveitis research in financial year 2023-24.The total commitment across UKRI in 2023-24 for uveitis research was £248,809 for 1 award (1 award from MRC).CataractNIHR allocated £2,584,219 for research concerning cataracts research in financial year 2023-24.The total commitment across UKRI in 2023-24 for cataract research was £516,566 for 1 award (1 award from Innovate UK).KeratoconusNIHR allocated £49,458 for research concerning keratoconus research in financial year 2023-24.The total commitment across UKRI in 2023-24 for keratoconus research was £516,566 for 1 award (1 award from Innovate UK).BlepharitisNIHR did not commit any specific funding for blepharitis research in financial year 2023-24.UKRI did not commit any specific funding for blepharitis research in 2023-24.Central Retinal Vein OcclusionNIHR allocated £70,000 for research concerning central retinal vein occlusion in the financial year 2023-24.UKRI did not commit any specific funding for central retinal vein occlusion research in 2023-24.Retinal Detachment Occlusion ResearchNIHR did not commit any specific funding for retinal detachment occlusion research in financial year of 2023-24.The total commitment across UKRI in 2023-24 for retinal detachment occlusion research was £1,223,830 for 1 award (1 award from MRC).

Innovation and Technology, how much Government funding into cataract research there was in 2023-24; and which public bodies provided that funding.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was awarded £20 million funding for a five-year period starting from December 2022.UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally. UKRI delivers a substantial portfolio of researcher-led projects. This includes a wide variety of areas including physiological, biological, and mechanistic aspects that are applicable to many eye diseases and disorders of vision.Details of UKRI and NIHR funding on specific areas is provided in the table below: NIHR funding in FY 2023/24UKRI Funding in 2023/24UveitisNIHR did not commit any specific funding for uveitis research in financial year 2023-24.The total commitment across UKRI in 2023-24 for uveitis research was £248,809 for 1 award (1 award from MRC).CataractNIHR allocated £2,584,219 for research concerning cataracts research in financial year 2023-24.The total commitment across UKRI in 2023-24 for cataract research was £516,566 for 1 award (1 award from Innovate UK).KeratoconusNIHR allocated £49,458 for research concerning keratoconus research in financial year 2023-24.The total commitment across UKRI in 2023-24 for keratoconus research was £516,566 for 1 award (1 award from Innovate UK).BlepharitisNIHR did not commit any specific funding for blepharitis research in financial year 2023-24.UKRI did not commit any specific funding for blepharitis research in 2023-24.Central Retinal Vein OcclusionNIHR allocated £70,000 for research concerning central retinal vein occlusion in the financial year 2023-24.UKRI did not commit any specific funding for central retinal vein occlusion research in 2023-24.Retinal Detachment Occlusion ResearchNIHR did not commit any specific funding for retinal detachment occlusion research in financial year of 2023-24.The total commitment across UKRI in 2023-24 for retinal detachment occlusion research was £1,223,830 for 1 award (1 award from MRC).

Innovation and Technology, how much Government funding into blepharitis research there was in 2023-24; and which public bodies provided that funding.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was awarded £20 million funding for a five-year period starting from December 2022.UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally. UKRI delivers a substantial portfolio of researcher-led projects. This includes a wide variety of areas including physiological, biological, and mechanistic aspects that are applicable to many eye diseases and disorders of vision.Details of UKRI and NIHR funding on specific areas is provided in the table below: NIHR funding in FY 2023/24UKRI Funding in 2023/24UveitisNIHR did not commit any specific funding for uveitis research in financial year 2023-24.The total commitment across UKRI in 2023-24 for uveitis research was £248,809 for 1 award (1 award from MRC).CataractNIHR allocated £2,584,219 for research concerning cataracts research in financial year 2023-24.The total commitment across UKRI in 2023-24 for cataract research was £516,566 for 1 award (1 award from Innovate UK).KeratoconusNIHR allocated £49,458 for research concerning keratoconus research in financial year 2023-24.The total commitment across UKRI in 2023-24 for keratoconus research was £516,566 for 1 award (1 award from Innovate UK).BlepharitisNIHR did not commit any specific funding for blepharitis research in financial year 2023-24.UKRI did not commit any specific funding for blepharitis research in 2023-24.Central Retinal Vein OcclusionNIHR allocated £70,000 for research concerning central retinal vein occlusion in the financial year 2023-24.UKRI did not commit any specific funding for central retinal vein occlusion research in 2023-24.Retinal Detachment Occlusion ResearchNIHR did not commit any specific funding for retinal detachment occlusion research in financial year of 2023-24.The total commitment across UKRI in 2023-24 for retinal detachment occlusion research was £1,223,830 for 1 award (1 award from MRC).

Innovation and Technology, what the total amount of Government investment into retinal detachment occlusion research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was awarded £20 million funding for a five-year period starting from December 2022.UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally. UKRI delivers a substantial portfolio of researcher-led projects. This includes a wide variety of areas including physiological, biological, and mechanistic aspects that are applicable to many eye diseases and disorders of vision.Details of UKRI and NIHR funding on specific areas is provided in the table below: NIHR funding in FY 2023/24UKRI Funding in 2023/24UveitisNIHR did not commit any specific funding for uveitis research in financial year 2023-24.The total commitment across UKRI in 2023-24 for uveitis research was £248,809 for 1 award (1 award from MRC).CataractNIHR allocated £2,584,219 for research concerning cataracts research in financial year 2023-24.The total commitment across UKRI in 2023-24 for cataract research was £516,566 for 1 award (1 award from Innovate UK).KeratoconusNIHR allocated £49,458 for research concerning keratoconus research in financial year 2023-24.The total commitment across UKRI in 2023-24 for keratoconus research was £516,566 for 1 award (1 award from Innovate UK).BlepharitisNIHR did not commit any specific funding for blepharitis research in financial year 2023-24.UKRI did not commit any specific funding for blepharitis research in 2023-24.Central Retinal Vein OcclusionNIHR allocated £70,000 for research concerning central retinal vein occlusion in the financial year 2023-24.UKRI did not commit any specific funding for central retinal vein occlusion research in 2023-24.Retinal Detachment Occlusion ResearchNIHR did not commit any specific funding for retinal detachment occlusion research in financial year of 2023-24.The total commitment across UKRI in 2023-24 for retinal detachment occlusion research was £1,223,830 for 1 award (1 award from MRC).

Innovation and Technology, how much Government funding into keratoconus research there was in 2023-24; and which public bodies provided that funding.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was awarded £20 million funding for a five-year period starting from December 2022.UKRI’s Medical Research Council (MRC) also plays a key role in funding underpinning research which may not be attributable to a specific condition but will benefit medical research more generally. UKRI delivers a substantial portfolio of researcher-led projects. This includes a wide variety of areas including physiological, biological, and mechanistic aspects that are applicable to many eye diseases and disorders of vision.Details of UKRI and NIHR funding on specific areas is provided in the table below: NIHR funding in FY 2023/24UKRI Funding in 2023/24UveitisNIHR did not commit any specific funding for uveitis research in financial year 2023-24.The total commitment across UKRI in 2023-24 for uveitis research was £248,809 for 1 award (1 award from MRC).CataractNIHR allocated £2,584,219 for research concerning cataracts research in financial year 2023-24.The total commitment across UKRI in 2023-24 for cataract research was £516,566 for 1 award (1 award from Innovate UK).KeratoconusNIHR allocated £49,458 for research concerning keratoconus research in financial year 2023-24.The total commitment across UKRI in 2023-24 for keratoconus research was £516,566 for 1 award (1 award from Innovate UK).BlepharitisNIHR did not commit any specific funding for blepharitis research in financial year 2023-24.UKRI did not commit any specific funding for blepharitis research in 2023-24.Central Retinal Vein OcclusionNIHR allocated £70,000 for research concerning central retinal vein occlusion in the financial year 2023-24.UKRI did not commit any specific funding for central retinal vein occlusion research in 2023-24.Retinal Detachment Occlusion ResearchNIHR did not commit any specific funding for retinal detachment occlusion research in financial year of 2023-24.The total commitment across UKRI in 2023-24 for retinal detachment occlusion research was £1,223,830 for 1 award (1 award from MRC).

Innovation and Technology, how much Government investment into wet macular degeneration was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was ...

Innovation and Technology, how much Government investment into closed-angle glaucoma research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was ...

Innovation and Technology, how much Government investment into open-angle glaucoma research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was ...

Innovation and Technology, what discussions he has had with the Regulatory Innovation Office on the UK’s research into nanotechnology since July 2024.

The Regulatory Innovation Office (RIO) was formally established on 8th October 2024. Initially it is supporting the growth of four fast-growing areas of technology. These are:  Engineering biology, Space, Artificial Intelligence and digital in healthcare;...

Innovation and Technology, what discussions he has had with the Government Office for Technology Transfer on their approach to support market innovation into nanotechnology since July 2024.

The Government Office for Technology Transfer (GOTT) helps accelerate government’s innovations towards the market, to impact growth and deliver new products and services for citizens. GOTT provides expertise, funding, and guidance to central government de...

Innovation and Technology, how much Government investment into retinoblastoma research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was ...

Innovation and Technology, how much Government investment into retinitis pigmentosa research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was ...

Innovation and Technology, how much Government investment into diabetic retinopathy research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was ...

Innovation and Technology, how much Government investment into dry macular degeneration research was in 2023-24; and which public bodies provided that investment.

The Department of Health and Social Care funds medical research through the National Institute for Health and Care Research (NIHR). The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology was ...

Innovation and Technology, what discussions he has had with the Arts and Humanities Research Council on its approach to supporting research into space weather and its consequences since July 2024.

Ministers have had no such discussions.However, as a part of their portfolio UKRI work with the Met Office to deliver the Space weather instrumentation, measurement, modelling and risk (SWIMMR), a £20 million, four-year programme that will improve the UK’...

Innovation and Technology, what discussions he has had since with the Engineering and Physical Sciences Research Council on its approach to supporting research into space weather and its consequences since July 2

Ministers have had no such discussions.However, as a part of their portfolio UKRI work with the Met Office to deliver the Space weather instrumentation, measurement, modelling and risk (SWIMMR), a £20 million, four-year programme that will improve the UK’...

Innovation and Technology, what discussions he has had with the Economic and Social Research Council on its approach to supporting research into space weather and its consequences since July 2024.

Ministers have had no such discussions.However, as a part of their portfolio UKRI work with the Met Office to deliver the Space weather instrumentation, measurement, modelling and risk (SWIMMR), a £20 million, four-year programme that will improve the UK’...

Innovation and Technology, what discussions he has had with the Medical Research Council on its approach to supporting research into space weather and its consequences since July 2024.

Ministers have had no such discussions.However, as a part of their portfolio UKRI work with the Met Office to deliver the Space weather instrumentation, measurement, modelling and risk (SWIMMR), a £20 million, four-year programme that will improve the UK’...

Innovation and Technology, what discussions he has had with the Natural Environment Research Council on its approach to support research into space weather and its consequences since July 2024.

Ministers have had no such discussions.However, as a part of their portfolio UKRI work with the Met Office to deliver the Space weather instrumentation, measurement, modelling and risk (SWIMMR), a £20 million, four-year programme that will improve the UK’...